TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Stocks for Beginners
Are Marijuana Stocks the Right Choice in the Current Market Environment?
Investing
Why You Shouldn’t Expect Pot to Be Legalized by July
Investing
Canopy Growth Corp.: Is it a Buy at $27?
Investing
The TSX Is Down Again: Why it Could Get Even Worse
Investing
Aphria Inc. Decides to Sell U.S. Investments After All
Investing
Is Now the Time to Buy Cannabis Firms as Valuation Multiples Come Down?
Investing
Aurora Cannabis Inc. Makes Another Big Move
Investing
Where Ontario’s Minimum Wage Increase Is Most Likely to Hurt Cannabis Producers
Investing
Are Marijuana Stocks Heading for a Bitcoin-Type Crash?
Investing
When Will it Be Safe to Get Back Into Cannabis Stocks?
Investing
Marijuana Stocks: Is Canopy Growth Corp. a Buy After Plummeting 42% From Highs?